Glucose Targets and Heart Disease: Does A1c Matter?

Dr. Ildiko Lingvay stresses the importance of glucose control and the cardio(renal) benefits of GLP-1RA and SGLT2 inhibitors.


Created by

Scripps CME Connection

Related Presenters

Ildiko Lingvay, MD

Ildiko Lingvay, MD

Professor of Medicine
Medical Director, Office of Clinical Trial Management
UT Southwestern Medical Center
Dallas, Texas

Ildiko Lingvay, MD, is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and an endocrinologist who specializes in clinical research in the fields of obesity, diabetes, and metabolic complications.

View full profile